Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In idiopathic pulmonary fibrosis, the quantitation of disease severity using pulmonary function tests is often confounded by emphysema. We have identified the composite physiologic index (CPI) most closely reflecting the morphologic extent of pulmonary fibrosis. Consecutive patients with a clinical/computed tomography (CT) diagnosis of idiopathic pulmonary fibrosis (n = 212) were divided into group I (n = 106) and group II (n = 106). The CPI was derived in group I (by fitting pulmonary function tests against disease extent on CT) and was tested in Group II. The formula for the CPI was as follows: extent of disease on CT = 91.0 − (0.65 × percent predicted diffusing capacity for carbon monoxide [DLCO]) − (0.53 × percent predicted FVC) + (0.34 × percent predicted FEV1). In group II, the CPI correlated more strongly with disease extent on CT (r2 = 0.51) than the individual pulmonary function test (DLCO the highest value, r2 = 0.38). A subanalysis demonstrated that the better fit of the CPI was ascribable to a correction of the confounding effects of emphysema. Mortality was predicted more accurately by the CPI than by a pulmonary function test in all clinical subgroups, including a separate cohort of 36 patients with histologically proven usual interstitial pneumonia (CPI, p < 0.0005; FVC, p = 0.002; PO2, p = 0.002). In conclusion, a new CPI, derived against CT and validated using split sample testing, is a more accurate prognostic determinant in usual interstitial pneumonia than an individual pulmonary function test.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the Composite Physiologic Index (CPI) and the Gender-Age-Physiology (GAP) index have been most commonly applied for estimating the survival of patients with IPF [3–6].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
In the citing paper
“CPI quantifies pulmonary function impairment due to pulmonary fibrosis, which is then correlated with the extent of fibrosis in computed tomography while excluding emphysema [3].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
Citations
Cites
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Austin, J. H., Müller, N. L., Friedman, P. J., Hansell, D. M., Naidich, D. P., Remy-Jardin, M., Webb, W. R., & Zerhouni, E. A. (1996) · Radiology · doi:10.1148/radiology.200.2.8685321 · Cited by 836
Self-citationHistopathologic Variability in Usual and Nonspecific Interstitial Pneumonias
FLAHERTY, K. R., TRAVIS, W. D., COLBY, T. V., TOEWS, G. B., KAZEROONI, E. A., GROSS, B. H., JAIN, A., STRAWDERMAN, R. L., FLINT, A., LYNCH, J. P., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103074 · Cited by 665
Self-citationIdeal Alveolar Air and the Analysis of Ventilation-Perfusion Relationships in the Lungs
Riley, R. L., & Cournand, A. (1949) · Journal of Applied Physiology · doi:10.1152/jappl.1949.1.12.825 · Cited by 563
Travis, W. D., Matsui, K., Moss, J., & Ferrans, V. J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00003 · Cited by 530
NICHOLSON, A. G., COLBY, T. V., DUBOIS, R. M., HANSELL, D. M., & WELLS, A. U. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003049 · Cited by 489
Self-citationIdiopathic Pulmonary Fibrosis: Predicting Response to Therapy and Survival
GAY, S. E., KAZEROONI, E. A., TOEWS, G. B., LYNCH, J. P., GROSS, B. H., CASCADE, P. N., SPIZARNY, D. L., FLINT, A., ANTHONY SCHORK, M., WHYTE, R. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9703022 · Cited by 406
Determinants of survival in idiopathic pulmonary fibrosis.
Schwartz, D. A., Helmers, R. A., Galvin, J. R., Van Fossen, D. S., Frees, K. L., Dayton, C. S., Burmeister, L. F., & Hunninghake, G. W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.8306044 · Cited by 340
Research works printed but not linked: 7
- 1995, Am J Respir Crit Care Med, 151, 1180
- 1997, Arthritis Rheum, 40, 1229
- 1983, Clin Respir Physiol, 19, 1
- 1994, Am J Respir Crit Care Med, 149, 450, 10.1164/ajrccm.149.2.8306044 · DOI · Paper page
- 1983, Am Rev Respir Diagn, 2, 43
- 1976, Chest, 69, 263
- 1995, Am J Respir Crit Care Med, 151, 1180
Cited by
Items 301–400 of 705
Plasma Metabolic Profiling in Patients With Silicosis and Asbestosis
Zhou, M., Xue, C., Fan, Y., Wu, N., Ma, J., & Ye, Q. (2021) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002232 · Cited by 27
“To avoid bias caused by emphysema, the composite physiologic index (CPI) was selected as a predictor of the severity of pulmonary fibrosis.(25) All patients completed a standardized questionnaire to collect information on their occupational history.”
MethodBerend, N. (2014) · Respirology · doi:10.1111/resp.12348 · Cited by 27
Pulmonary function vascular index predicts prognosis in idiopathic interstitial pneumonia
Corte, T. J., Wort, S. J., Macdonald, P. S., Edey, A., Hansell, D. M., Renzoni, E. A., Maher, T. M., Nicholson, A. G., Bandula, S., Bresser, P., et al. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02121.x · Cited by 27
Self-citationPlasma metabolomic profile in fibrosing pulmonary sarcoidosis.
Mirsaeidi, M. S., Banoei, M. M., Nienow, C. K., Abassi, T., Hakim, A., Schraufnagel, D. E., Winston, B. W., Sweiss, N., Baughman, R. P., Garcia, J. G. N., et al. (2016) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 32
Bone mineral density in patients with idiopathic pulmonary fibrosis
Ikezoe, K., Handa, T., Tanizawa, K., Kubo, T., Oguma, T., Hamada, S., Watanabe, K., Aihara, K., Sokai, A., Nakatsuka, Y., et al. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.06.014 · Cited by 26
Achaiah, A., Rathnapala, A., Pereira, A. Z., Bothwell, H., Dwivedi, K., Barker, R., Benamore, R. E., Hoyles, R. K., Iotchkova, V., & Ho, L. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-000899 · Cited by 30
Wu, X., Yin, C., Chen, X., Zhang, Y., Su, Y., Shi, J., Weng, D., Jiang, X., Zhang, A., Zhang, W., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878764 · Cited by 27
“The patient’s PF parameters are indispensable for prognosis estimation (Wells et al., 2003; Ley et al., 2012).”
BackgroundMethodCharacterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis
Schimmelpennink, M. C., Meek, D. B., Vorselaars, A. D. M., Langezaal, L. C. M., van Moorsel, C. H. M., van der Vis, J. J., Veltkamp, M., & Grutters, J. C. (2022) · Respiratory Research · doi:10.1186/s12931-022-02094-7 · Cited by 26
Predicting prognosis in idiopathic pulmonary fibrosis.
Barlo, N. P., van Moorsel, C. H. M., van den Bosch, J. M. M., & Grutters, J. C. (2010) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 31
Chiba, S., Ohta, H., Abe, K., Hisata, S., Ohkouchi, S., Hoshikawa, Y., Kondo, T., & Ebina, M. (2012) · Pulmonary Medicine · doi:10.1155/2012/492960 · Cited by 26
“The composite physiologic index (CPI) was calculated as follows [6]:”
BackgroundMethodJeny, F., Brillet, P., Kim, Y.-W., Freynet, O., Nunès, H., & Valeyre, D. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1556639 · Cited by 29
“The CPI was predictive of mortality in or IPF [143], or”
BackgroundLynch, J. P., & Belperio, J. A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9771-5_10 · Cited by 26
Cottin, V., Crestani, B., Cadranel, J. L., Cordier, J. F., Marchand-Adam, S., Prévot, G., Wallaert, B., Bergot, E., Camus, P., Dalphin, J., et al. (2017) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2017.07.018 · Cited by 25
“Lorsqu’on ne dispose pas de la DLco pour calculer le score GAP, un score de fibrose au scanner peut apporter la même information pronostique [70] ; • le score CPI (composite physiologic index) peut être utilisé pour évaluer la gravité de la fibrose indépendamment de l’existence éventuelle d’emphysème [71] ; • une exac…”
BackgroundBalestro, E., Cocconcelli, E., Giraudo, C., Polverosi, R., Biondini, D., Lacedonia, D., Bazzan, E., Mazzai, L., Rizzon, G., Lococo, S., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091469 · Cited by 26
Kalafatis, D., Löfdahl, A., Näsman, P., Dellgren, G., Wheelock, Å. M., Elowsson, L., Sköld, M. C., & Westergren‐Thorsson, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413421 · Cited by 25
“Four measures of disease severity were considered: FVC %, DLco %, TLC %, and the composite physiologic index (CPI), which correlates with the fibrotic extent seen in radiology [92].”
BackgroundSix-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil
Mancuzo, E. V., Soares, M. R., & Pereira, C. A. D. C. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562018000000049 · Cited by 25
“Various studies have appeared in the past years with this proposal, some even emphasizing the six-minute walk distance (6MWD) as having prognostic value.(10-15)”
BackgroundDefining genetic risk factors for scleroderma-associated interstitial lung disease
Stock, C. J. W., Lauretis, A. D., Visca, D., Daccord, C., Kokosi, M. A., Kouranos, V., Margaritopoulos, G. A., George, P. M., Molyneaux, P. L., Nihtyanova, S. I., et al. (2020) · Clinical Rheumatology · doi:10.1007/s10067-019-04922-6 · Cited by 26
Self-citationReadily accessible CT scoring method to quantify fibrosis in IPF
Fraser, E., Noble, V. S., Hoyles, R. K., Benamore, R. E., & Ho, L. (2020) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000584 · Cited by 25
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover
Sésé, L., Caliez, J., Annesi‐Maesano, I., Cottin, V., Pesce, G., Didier, M., Carton, Z., Israël‐Biet, D., Crestani, B., Guillot, S., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106415 · Cited by 26
“Gender Age Physiology (GAP) staging was based on Ley et al.[13] and the composite physiologic index (CPI) was calculated according to Wells et al.[14].”
Monitoring of Lung Involvement in Rheumatologic Disease
Paschalaki, K. E., Jacob, J., & Wells, A. U. (2016) · Respiration · doi:10.1159/000442890 · Cited by 24
Self-citationFernandez, I. E., Amarie, O. V., Mutze, K., Königshoff, M., Yildirim, A. Ö., & Eickelberg, O. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00183.2015 · Cited by 28
Trăilă, D., Oancea, C. I., Tudorache, E., Firă-Mladinescu, O., Timar, B., & Tudorache, V. (2017) · Journal of International Medical Research · doi:10.1177/0300060517719767 · Cited by 26
“13 The CPI, which uses the forced expiratory volume in 1 second (FEV1), FVC, and DLCO, quantifies functional impairment specifically due to pulmonary fibrosis, removing the confounding functional effects of coexistent emphysema.(14)”
MethodBiondini, D., Balestro, E., Lacedonia, D., Cerri, S., Milaneschi, R., Luppi, F., Cocconcelli, E., Bazzan, E., Clini, E. M., Barbaro, M. P. F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24303-4 · Cited by 25
Risk Prediction in Idiopathic Pulmonary Fibrosis
Ley, B., & Collard, H. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-1960ed · Cited by 24
Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
Kärkkäinen, M., Kettunen, H.-P., Nurmi, H., Selander, T., Purokivi, M., & Kaarteenaho, R. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0996-2 · Cited by 23
Pulmonary Function in Pulmonary Sarcoidosis
Yao, Q., Ji, Q., & Zhou, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216701 · Cited by 23
Zhao, R., Xie, B., Wang, X., Zhang, X., Ren, Y., Wang, C., & Dai, H. (2024) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2024.102287 · Cited by 24
Sverzellati, N., Devaraj, A., Desai, S. R., Quigley, M., Wells, A. U., & Hansell, D. M. (2011) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0b013e3182277d05 · Cited by 23
Self-citationCocconcelli, E., Balestro, E., Biondini, D., Barbiero, G., Polverosi, R., Calabrese, F., Pezzuto, F., Lacedonia, D., Rea, F., Schiavon, M., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030399 · Cited by 24
Alfieri, V., Crisafulli, E., Visca, D., Chong, W. H., Stock, C. J. W., Mori, L., Lauretis, A. D., Tsipouri, V., Chua, F., Kouranos, V., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01681-2019 · Cited by 23
Self-citationSugino, K., Nakamura, Y., Ito, T., Isshiki, T., Sakamoto, S., & Homma, S. A. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 23
Papaioannou, A. Ι., Κostikas, Κ., Manali, E. D., Papadaki, G. F., Roussou, A., Spathis, A., Mazioti, A., Tomos, I. P., Papanikolaou, I. C., Loukides, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157789 · Cited by 25
“Interestingly, in our study circulating levels of SP-A, correlated to CPI in patients with IPF, CPI being a composite score found to be an important indicator of the total respiratory impairment in IPF and related to the total extent of fibrosis in these patients [37].”
BackgroundPredictive factors of obstructive sleep apnoea in patients with fibrotic lung diseases
Pereira, N. B. B. L., Cardoso, A. V., Mota, P. C., Santos, A. C., Melo, N. C. V., Morais, A., & Drummond, M. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.01.020 · Cited by 23
Diagnosis and Management of Fibrotic Interstitial Lung Diseases
Collins, B. F., & Luppi, F. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2021.03.008 · Cited by 22
99mTc-Labeled FAPI SPECT Imaging in Idiopathic Pulmonary Fibrosis: Preliminary Results
Liu, Y., Zhang, Q., Zhang, Y., Wang, J., Wu, Y., Yang, G., Shi, J., Wang, F., Xu, Z., & Jing, H. (2023) · Pharmaceuticals · doi:10.3390/ph16101434 · Cited by 22
“The composite physiologic index (CPI) was also calculated based on the previous literature using the following formula: CPI = 91.0 − (0.65 × percent predicted DLCO) − (0.53 × percent predicted FVC) + (0.34 × percent predicted FEV1) [38].”
MethodInfluentialA modified GAP model for East-Asian populations with idiopathic pulmonary fibrosis
Nishikiori, H., Chiba, H., Lee, S. H., Kondoh, S., Kamo, K., Nakamura, K., Ikeda, K., Kuronuma, K., Chung, M. P., Kondoh, Y., et al. (2020) · Respiratory Investigation · doi:10.1016/j.resinv.2020.04.001 · Cited by 22
Majewski, S., Szewczyk, K., Jerczyńska, H., Miłkowska-Dymanowska, J., Białas, A. J., Gwadera, Ł., & Piotrowski, W. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.760776 · Cited by 22
Recent advances in the diagnosis and management of nonspecific interstitial pneumonia
Drent, M., du Bois, R. M., & Poletti, V. E. (2003) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200309000-00013 · Cited by 22
Jee, A. S., Parker, M. J. S., Bleasel, J. F., Troy, L. K., Lau, E., Jo, H. E., Teoh, A. K. Y., Adelstein, S., Webster, S. E., & Corte, T. J. (2021) · Respiration · doi:10.1159/000515396 · Cited by 22
Macaluso, C., Boccabella, C., Kokosi, M. A., Sivarasan, N., Kouranos, V., George, P. M., Margaritopoulos, G. A., Molyneaux, P. L., Chua, F., Maher, T. M., et al. (2022) · Respirology · doi:10.1111/resp.14204 · Cited by 22
Self-citationYeo, J., Yoon, S. H., Kim, J. Y., Lee, J. S., Lee, E. Y., Goo, J. M., Pourzand, L., Goldin, J. G., Kim, G. H. J., & Ha, Y. (2023) · Rheumatology · doi:10.1093/rheumatology/kead122 · Cited by 21
Novel diagnostic techniques in interstitial lung disease
Glenn, L. M., Troy, L. K., & Corte, T. J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1174443 · Cited by 21
Nakagawa, H., Ogawa, E., Fukunaga, K., Kinose, D., Yamaguchi, M., Nagao, T., Tanaka‐Mizuno, S., & Nakano, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214278 · Cited by 25
Cottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100948 · Cited by 25
Interstitial lung disease in systemic sclerosis
Renzoni, E. A. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2007.478 · Cited by 24
Management of dyspnea in interstitial lung disease
Ryerson, C. J., Collard, H. R., & Pantilat, S. Z. (2010) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3283392b51 · Cited by 23
Fibrotic idiopathic interstitial pneumonias: Mortality is linked to a decline in gas transfer
Peelen, L. M., Wells, A. U., Prijs, M., Blumenthal, J., van Steenwijk, R. P., Jonkers, R. E., Peek, N. B., & Bresser, P. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01862.x · Cited by 22
Self-citationRespiratory failure in interstitial lung disease
Bag, R., Suleman, N., & Guntupalli, K. K. (2004) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000136404.09581.41 · Cited by 22
Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study
Guler, S. A., Machahua, C., Geiser, T., Kocher, G. J., Marti, T. M., Tan, B., Trappetti, V., Ryerson, C. J., & Funke-Chambour, M. (2022) · Respiratory Research · doi:10.1186/s12931-022-02076-9 · Cited by 20
Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally
Gredic, M., Karnati, S., Ruppert, C., Guenther, A., Avdeev, S. N., & Kosanovic, D. (2023) · Cells · doi:10.3390/cells12091278 · Cited by 20
Proton Pump Inhibitors in IPF: A Call for Clinical Trials
Ghebre, Y. T. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00499 · Cited by 21
“…Chicago reported that IPF patients on “antireflux therapy” (95% were on PPIs) had significantly better lung function (as shown by greater diffusing capacity for carbon monoxide; DLCO) and reduced composite physiologic index (CPI); a validated measure of disease severity in IPF (Wells et al., 2003).”
BackgroundOscillometry and computed tomography findings in patients with idiopathic pulmonary fibrosis
Yamamoto, Y., Miki, K., Tsujino, K., Kuge, T., Okabe, F., Kawasaki, T., Matsuki, T., Kagawa, H., Miki, M., & Kida, H. (2020) · ERJ Open Research · doi:10.1183/23120541.00391-2020 · Cited by 20
Baughman, R. P., Gupta, R., Judson, M. A., Lower, E. E., Birring, S. S., Stewart, J. I., Reeves, R., & Wells, A. U. (2022) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v39i2.12940 · Cited by 20
Self-citationIdiopathic pulmonary fibrosis.
Balamugesh, T., & Behera, D. (2007) · PubMed · Cited by 20
Cardoso, A. V., Pereira, N., Neves, I. F., Santos, V., Jesus, J. M., Melo, N. C. V., Mota, P. C., Morais, A., & Drummond, M. (2018) · Canadian Journal of Respiratory Therapy · doi:10.29390/cjrt-2018-005 · Cited by 20
“Fibrosis score The radiological extent of pulmonary fibrosis was evaluated using the same fibrosis score as that used in the composite physiological index validation [26].”
BackgroundMethodΤzouvelekis, Α., Tzilas, V., Papiris, S. A., Aidinis, V., & Bouros, D. E. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.12.002 · Cited by 20
Robbie, H., Wells, A. U., Fang, C., Jacob, J., Walsh, S. L. F., Nair, A., Camoras, R., Desai, S. R., & Devaraj, A. (2021) · European Radiology · doi:10.1007/s00330-021-08338-2 · Cited by 19
Self-citationKim, H. J., Snyder, L. D., Neely, M. L., Hellkamp, A. S., Hotchkin, D. L., Morrison, L. D., Bender, S. D., Leonard, T. B., Culver, D. A., & the IPF-PRO™ Registry investigators (2022) · Lung · doi:10.1007/s00408-021-00506-x · Cited by 20
Clinico-radio-pathological characteristics of unclassifiable idiopathic interstitial pneumonias
Nakamura, Y., Sugino, K., Kitani, M., Hebisawa, A., Tochigi, N., & Homma, S. A. (2017) · Respiratory Investigation · doi:10.1016/j.resinv.2017.09.001 · Cited by 20
Risk Factors and Outcomes in Dogs With Respiratory Disease Undergoing Diagnostic Airway Lavage
Bianco, Z., Bukoski, A. D., Masseau, I., Reich, C., Schultz, L. G., & Reinero, C. R. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00165 · Cited by 19
Stock, C. J. W., Conti, C., Montero, Á., Caramori, G., Molyneaux, P. L., George, P. M., Kokosi, M. A., Kouranos, V., Maher, T. M., Chua, F., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-214579 · Cited by 18
“34xFEV1%) as a measure of disease severity[4] was analysed using generalised linear models with the CPI as the dependent variable and the T-carrier and/or mean percentage of MUC5B+ cells per patient as independent variables.”
MethodSelf-citationŠtefániková, M., Doubková, M., Ovesná, P., Šterclová, M., Lacina, L., Žůrková, M., Plačková, M., Bartoš, V., Janíčková, I., Bittenglová, R., et al. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02450-3 · Cited by 19
“34×forced expiratory volume [FEV1] % pred) [17].”
Chandel, A., King, C. S., Ignacio, R. V., Pastré, J., Shlobin, O. A., Khangoora, V. S., Aryal, S., NYQUIST, A. S., SINGHAL, A. L., Flaherty, K. R., et al. (2023) · ERJ Open Research · doi:10.1183/23120541.00124-2023 · Cited by 18
Molecular Biomarkers in Interstitial Lung Diseases
Lauretis, A. D., & Renzoni, E. A. (2014) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-014-0109-0 · Cited by 21
“In the idiopathic interstitial pneumonias (IIPs), a number of baseline parameters have been linked to future disease progression and survival, including histopathological pattern [28–30], severity of disease at baseline (CT [31–33] and/or lung function parameters including forced vital capacity [FVC] and diffusing cap…”
BackgroundOhgiya, M., Matsui, H., Tamura, A., Kato, T., Akagawa, S., & Ohta, K. (2017) · Internal Medicine · doi:10.2169/internalmedicine.8406-16 · Cited by 18
Perelas, A., Glennie, J., van Kerkhove, K., Li, M., Scheraga, R. G., Olman, M. A., & Culver, D. A. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.101839 · Cited by 18
“The gender-age-physiology (GAP) and the composite physiologic index (CPI) scores were calculated at the time of therapy initiation [5, 6].”
MethodSadeleer, L. D., Goos, T., Yserbyt, J., & Wuyts, W. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061722 · Cited by 20
“In 2003, Wells and colleagues constructed the composite physiological index (CPI), an estimator of fibrosis extent on CT based on FVC, DLCO and forced expiratory volume in 1 second (FEV1), which proved to be associated with mortality [36].”
BackgroundPastré, J., Barnett, S. D., Ksovreli, I., Taylor, J., Brown, A. W., Shlobin, O. A., Ahmad, K., Khangoora, V. S., Aryal, S., King, C. S., et al. (2021) · Respiratory Research · doi:10.1186/s12931-020-01600-z · Cited by 19
“The GAP index (gender, age, physiology) is the most commonly accepted prognostic scoring system with others such as the composite physiologic index (CPI) also in existence, but neither of these includes a measure of functional ability or need for supplemental oxygen [22, 23].”
BackgroundMoor, C. C., Tak, N. C., Owusuaa, C., Miedema, J., Baart, S. J., van der Rijt, C. C. D., & Wijsenbeek, M. S. (2021) · Respiration · doi:10.1159/000516291 · Cited by 18
Zinellu, A., Carru, C., Pirina, P., Fois, A. G., & Mangoni, A. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020498 · Cited by 21
Chronic Kidney Disease Predicts Survival in Patients with Idiopathic Pulmonary Fibrosis
Ikezoe, K., Handa, T., Tanizawa, K., Yokoi, H., Kubo, T., Aihara, K., Sokai, A., Nakatsuka, Y., Hashimoto, S., Uemasu, K., et al. (2017) · Respiration · doi:10.1159/000478787 · Cited by 18
Goos, T., Sadeleer, L. D., Yserbyt, J., Verleden, G. M., Vermant, M., Verleden, S. E., & Wuyts, W. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061330 · Cited by 17
High-resolution computed tomography in the diagnosis and follow-up of idiopathic pulmonary fibrosis
Sverzellati, N., Filippo, M. D., Bartalena, T., Piciucchi, S., & Zompatori, M. (2010) · La radiologia medica · doi:10.1007/s11547-010-0512-5 · Cited by 19
“Mentre il grado di ventilazione variabile che si osserva nella UIP, composta di spazi aerei cistici (che possono intrappolare l’aria o meno) e marcata fibrosi, probabilmente indebolisce le correlazioni tra estensione di malattia e gli indici volumetrici delle prove di funzionalità respiratoria, per una data estensione…”
BackgroundMethodInfluentialDerivation and Validation of a Diagnostic Prediction Tool for Interstitial Lung Disease
Pugashetti, J. V., Kitich, A., Alqalyoobi, S., Maynard-Paquette, A.-C., Pritchard, D., Graham, J., Boctor, N., Kulinich, A. G., LaFond, E., Foster, E. E., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.044 · Cited by 18
Stratégies d’interprétation des explorations fonctionnelles respiratoires
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R. H., Coates, A. L., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2007) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(07)91120-1 · Cited by 20
Advances in imaging of cardiopulmonary involvement in sarcoidosis
Kouranos, V., Hansell, D. M., Sharma, R., & Wells, A. U. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000195 · Cited by 16
“The composite physiologic index (previously validated in idiopathic pulmonary fibrosis) [42] and two HRCT variables (the extent of fibrosis and main pulmonary artery diameter to ascending aorta diameter ratio) were integrated to separate patients into low-risk and high-risk groups.”
MethodSelf-citationKomatsu, M., Yamamoto, H., Kitaguchi, Y., Kawakami, S., Matsushita, M., Uehara, T., Kinjo, T., Wada, Y., Ichiyama, T., Urushihata, K., et al. (2021) · Medicine · doi:10.1097/md.0000000000025322 · Cited by 20
Physical activity decline is disproportionate to decline in pulmonary physiology in IPF
Prasad, J. D., Paul, E. M., Holland, A. E., Glaspole, I., & Westall, G. P. (2021) · Respirology · doi:10.1111/resp.14137 · Cited by 17
“Commonly used tools to predict outcomes in IPF include DLCO below 40% predicted,(6,9,31) decline in FVC by 10%,(6) 6MWD, oxygen desaturation(32) and composite scores such as CPI and GAP.(22,23) Wallaert et al.”
MethodInfluentialBarratt, S. L., Creamer, A. W., Adamali, H. I., Duckworth, A., Fallon, J., Fidan, S., Nancarrow, T., Wollerton, R. L., Steward, M., Gooptu, B., et al. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2021-001063 · Cited by 16
Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography
Zompatori, M., Leone, M. B., Giannotta, M., Galiè, N., Palazzini, M., Reggiani, M. L. B., Bono, L., & Pollini, G. S. (2013) · La radiologia medica · doi:10.1007/s11547-013-0934-1 · Cited by 16
Antoniou, K. M., Malagari, K. S., Tzanakis, Ν., Perisinakis, K., Symvoulakis, E. K., Karkavitsas, N. S., Siafakas, N. M., & Bouros, D. E. (2006) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-6-4 · Cited by 16
Pulmonary fibrosis, part II: state-of-the-art patient management
Meyer, K. C. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1312347 · Cited by 18
“assessment tools, are useful to clinically evaluate disease activity over time and make clinical decisions concerning disease progression and response to therapeutic interventions (84-90).”
BackgroundTreatment of lymphedema and patient rehabilitation.
Földi, E. (1998) · PubMed · Cited by 16
Sgalla, G., Larici, A. R., Sverzellati, N., Bartholmai, B., Walsh, S. L. F., Nikolic, D., Barney, A., Fletcher, S., Jones, M., Davies, D. D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.02093-2018 · Cited by 15
Povitz, M., Li, L., Hosein, K., Shariff, S. Z., & Mura, M. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.03.012 · Cited by 15
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis
Pugashetti, J. V., Kim, J. S., Bose, S., Adegunsoye, A., Linderholm, A., Chen, C., Strek, M. E., Flaherty, K. R., Murray, S., Newton, C. A., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202310-1887oc · Cited by 15
Kishaba, T., Shimaoka, Y., Fukuyama, H., Nagano, H., Nei, Y., Yamashiro, S., & Tamaki, H. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2015.04.54 · Cited by 17
“We calculated the composite physiologic index (CPI) using the formula (19): CPI =91− (0.”
MethodSato, R., Handa, T., Matsumoto, H., Kubo, T., & Hirai, T. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-1012-6 · Cited by 17
Pires, F. S., Mota, P. C., Melo, N. C. V., Costa, D., Jesus, J. M., Cunha, R., Guimarães, S., Souto-Moura, C., & Morais, A. (2013) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppneu.2012.05.002 · Cited by 19
Aliboni, L., Dias, O. M., Pennati, F., Baldi, B. G., Sawamura, M. V. Y., Chate, R. C., de Carvalho, C. R. R., de Albuquerque, A. L. P., & Aliverti, A. (2020) · Academic Radiology · doi:10.1016/j.acra.2020.10.009 · Cited by 15
Syndrome d'emphysème des sommets et fibrose pulmonaire des bases combinés
Cottin, V., Brillet, P., Nunès, H., & Cordier, J.-F. (2007) · La Presse Médicale · doi:10.1016/j.lpm.2007.03.005 · Cited by 15
Kolb, M. R. J., Flaherty, K. R., Silva, R. S., Prasse, A., Vancheri, C., Mueller, H., Sroka, K., Wells, A. U., & on behalf of the INBUILD trial investigators (2023) · Advances in Therapy · doi:10.1007/s12325-023-02668-x · Cited by 17
Self-citationYang, S., Wang, J., Sun, D., Wang, Y., Xue, C., & Ye, Q. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1246767 · Cited by 14
Interstitial Lung Disease Epidemiology in the Past Three Decades: A Narrative Review
Puppo, F., & Carbone, R. G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237350 · Cited by 17
Minimal clinically important difference in idiopathic pulmonary fibrosis
Kang, M., Marts, L. T., Kempker, J. A., & Veeraraghavan, S. (2021) · Breathe · doi:10.1183/20734735.0345-2020 · Cited by 17
de Andrade, J. A., Kulkarni, T., Neely, M. L., Hellkamp, A. S., Case, A. H., Guntupalli, K. K., Bender, S. D., Conoscenti, C., & Snyder, L. D. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106637 · Cited by 14
Imaging of Idiopathic Pulmonary Fibrosis
Kusmirek, J. E., Martin, M. D., & Kanne, J. P. (2016) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2016.05.004 · Cited by 15
Fisher, J. H., Alhejaili, F. F., Kandel, S., Hirji, A. S., Shapera, S., & Mura, M. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.03.006 · Cited by 17
Staging systems and disease severity assessment in interstitial lung diseases
Tomassetti, S., Ryu, J. H., & Poletti, V. E. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000198 · Cited by 15
“[8] derived the composite physiologic index (CPI) from correlation of pulmonary function measures with disease extent seen on HRCT.”
BackgroundPortillo, K., Pérez-Rodas, N., García-Olivé, I., Guasch-Arriaga, I., Centeno, C., Serra, P., Becker-Lejuez, C., Santos, J. S., García, F. A., & Manzano, J. R. (2016) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2016.10.004 · Cited by 14
Metadata
- Authors
- Wells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M.
- Affiliations
- Mayo Clinic (US)
- Department of Radiology and Department of Physiology Royal Brompton Hospital, Interstitial Lung Disease Unit; Department of Radiology, King's College Hospital, London, United Kingdom; and Department of Pathology, Mayo Clinic, Scottsdale, Arizona
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 167
- Issue
- 7
- Pages
- 962-969
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3022958008
- Cited by
- 686
- References
- 32
- Citations by year
- 2026: 18 · 2025: 31 · 2024: 28 · 2023: 39 · 2022: 37 · 2021: 48 · 2020: 42 · 2019: 40 · 2018: 40 · 2017: 52 · 2016: 47 · 2015: 42 · 2014: 27 · 2013: 38 · 2012: 22
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, usual interstitial pneumonia, composite physiologic index, pulmonary function tests, diffusing capacity for carbon monoxide, mortality prediction, prognostic score
- MeSH terms
- Aged, Biopsy, Carbon Monoxide, Female, Follow-Up Studies, Forced Expiratory Volume, Humans, Lung, Male, Middle Aged, Monitoring, Physiologic, Predictive Value of Tests, Prognosis, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Fibrosis, Statistics as Topic, Tomography, X-Ray Computed, Total Lung Capacity, Vital Capacity, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.